Innovation Pharmaceuticals At Digestive Disease Week Conference, Nears Selecting Drug Formulation Company to Prepare Oral Brilacidin for Targeted Delivery in Ulcerative Colitis

Ads

You May Also Like

Basilea’s antifungal CRESEMBA(r) (isavuconazole) launched in Italy

BASEL, Switzerland, June 27, 2016 (GLOBE NEWSWIRE) -- Basilea Pharmaceutica Ltd. (SIX: BSLN) announces ...

TiGenix announces closing of NASDAQ IPO

Leuven (BELGIUM) - December 20, 2016, 16:00h CET - TiGenix NV (Euronext Brussels & NASDAQ: TIG; ...

BeiGene Announces Initiation of First Pivotal Study in China with BTK Inhibitor BGB-3111

BEIJING, March 02, 2017 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ:BGNE), a clinical-stage biopharmaceutical company ...